{"transactions":[{"id":2247803,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":126643,"kind":"person","name":"Jiao Jin-an","position":1,"cik":"0001866271","reported_name":"Jiao Jin-an","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T16:16:07.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":1714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"20% of the total shares subject to the stock option grant will vest on December 22, 2021; 20% of the total shares subject to the stock option grant will vest on December 22, 2022; 25% of the total shares subject to the stock option grant will vest on December 22, 2023; and 35% of the total shares subject to the stock option grant will vest on December 22, 2024."}],"balance_after":6857,"derivative":{"exercise_price":0.21,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":1714},"source":{"system":"sec-edgar","filing":"0001209191-22-033517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1866271/000120919122033517/doc4.xml","form_type":"4"}},{"id":2247802,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":126643,"kind":"person","name":"Jiao Jin-an","position":1,"cik":"0001866271","reported_name":"Jiao Jin-an","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T16:16:07.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":12856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These option shares were part of a stock option grant covering 51,428 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant will vest on May 30, 2022; and 35% of the total shares subject to the stock option grant will vest on May 30, 2023."}],"balance_after":18001,"derivative":{"exercise_price":0.14,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":12856},"source":{"system":"sec-edgar","filing":"0001209191-22-033517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1866271/000120919122033517/doc4.xml","form_type":"4"}},{"id":2247801,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":126643,"kind":"person","name":"Jiao Jin-an","position":1,"cik":"0001866271","reported_name":"Jiao Jin-an","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Development"}}],"security":"Common Stock","published_at":"2022-06-02T16:16:07.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":1714,"price":0.21,"value":359.94,"ownership":{"direct":true},"balance_after":45141,"source":{"system":"sec-edgar","filing":"0001209191-22-033517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866271/000120919122033517/doc4.xml","form_type":"4"}},{"id":2247800,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":126643,"kind":"person","name":"Jiao Jin-an","position":1,"cik":"0001866271","reported_name":"Jiao Jin-an","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Development"}}],"security":"Common Stock","published_at":"2022-06-02T16:16:07.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":12856,"price":0.14,"value":1799.84,"ownership":{"direct":true},"balance_after":43427,"source":{"system":"sec-edgar","filing":"0001209191-22-033517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866271/000120919122033517/doc4.xml","form_type":"4"}},{"id":2482530,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":126643,"kind":"person","name":"Jiao Jin-an","position":1,"cik":"0001866271","reported_name":"Jiao Jin-an","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Development"}}],"security":"Common Stock","published_at":"2021-12-07T12:31:49.000Z","date":"2021-12-06","kind":"purchase","acquired":true,"shares":10000,"price":2.415,"value":24150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.40 to $2.43. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":30571,"source":{"system":"sec-edgar","filing":"0001209191-21-068274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866271/000120919121068274/doc4.xml","form_type":"4"}},{"id":2573416,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":126643,"kind":"person","name":"Jiao Jin-an","position":1,"cik":"0001866271","reported_name":"Jiao Jin-an","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-10T17:45:22.000Z","date":"2021-09-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025."}],"balance_after":10000,"derivative":{"exercise_price":4.31,"expiration_date":"2031-09-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-055527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866271/000120919121055527/doc4.xml","form_type":"4"}}]}